Oliver Luxxe Assets LLC Pfizer Inc Transaction History

Oliver Luxxe Assets LLC

$458 Million
Q2 2024

A detailed history of Oliver Luxxe Assets LLC transactions in Pfizer Inc stock. As of the latest transaction made, Oliver Luxxe Assets LLC holds 18,626 shares of PFE stock, worth $552,447. This represents 0.11% of its overall portfolio holdings.

Number of Shares

18,626

Previous 18,563 0.34%

Holding current value

$552,447

Previous $515,000 1.17%

% of portfolio

0.11%

Previous 0.11%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $1,591 - $1,864	63 Added 0.34%	18,626 $521,000
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $11,231 - $13,128	-350 Reduced 1.85%	18,563 $615,000
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $33,952 - $39,282	-940 Reduced 4.73%	18,913 $693,000
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $2.72 Million - $3.54 Million	-69,089 Reduced 77.68%	19,853 $810,000
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $2,212 - $2,888	53 Added 0.06%	88,942 $4.56 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $45,116 - $55,076	1,031 Added 1.17%	88,889 $3.89 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $4,559 - $5,406	98 Added 0.11%	87,858 $4.61 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $9,607 - $11,904	-210 Reduced 0.24%	87,760 $4.54 Million
Q4 2021 Feb 16, 2022	SELL	$41.32 - $61.25 $70,491 - $104,492	-1,706 Reduced 1.9%	87,970 $5.2 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $130,349 - $167,444	3,321 Added 3.85%	89,676 $3.86 Million
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $30,990 - $35,106	-863 Reduced 0.99%	86,355 $3.38 Million
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $146,753 - $165,508	4,382 Added 5.29%	87,218 $3.16 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $362,747 - $461,265	-10,838 Reduced 11.57%	82,836 $3.13 Million
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $88,138 - $103,406	2,776 Added 3.05%	93,674 $3.44 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $35,963 - $43,628	-1,194 Reduced 1.3%	90,898 $2.97 Million
Q1 2020 Apr 21, 2020	SELL	$27.03 - $38.62 $498,433 - $712,152	-18,440 Reduced 16.68%	92,092 $3.19 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $15,834 - $17,970	481 Added 0.44%	110,532 $4.33 Million
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $251,700 - $326,381	7,747 Added 7.57%	110,051 $3.9 Million
Q2 2019 Jul 10, 2019	BUY	$36.98 - $41.52 $44,228 - $49,657	1,196 Added 1.18%	102,304 $4.43 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $124,275 - $136,536	-3,314 Reduced 3.17%	101,108 $4.29 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $274,021 - $312,414	-7,123 Reduced 6.39%	104,422 $4.56 Million
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $186,896 - $226,693	-5,422 Reduced 4.64%	111,545 $5.01 Million
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $189,736 - $220,120	-5,946 Reduced 4.84%	116,967 $4.15 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $47,195 - $50,076	-1,419 Reduced 1.14%	122,913 $4.45 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $3.85 Million - $4.25 Million	124,332	124,332 $4.44 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.

Account

Oliver Luxxe Assets LLC Pfizer Inc Transaction History